To include your compound in the COVID-19 Resource Center, submit it here.

Hepavir B: Phase I

In a European Phase I study, the number of adverse events associated

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE